Patents-Review.com
ClassID:

110273 ⎘

C12N2740/10034 - CPC Classification

Classification description:

Reverse transcribing RNA viruses; Details; Retroviridae Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260077031
2026-03-19

NUCLEIC ACIDS ENCODING HUMAN ENDOGENOUS RETROVIRUS K (HERV-K) ENVELOPE PROTEINS CONTAINING MODIFIED IMMUNOSUPPRESSIVE DOMAINS (ISD) AND USES THEREOF

 #2
20250376696
2025-12-11

VIRUS VECTOR PRODUCTION

 #3
20250186579
2025-06-12

VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE

 #4
20250032601
2025-01-30

METHODS OF MAKING AND USING UNIVERSAL CENTRALIZED INFLUENZA VACCINE GENES

 #5
20240417697
2024-12-19

METHODS AND COMPOSITIONS FOR BAT IPSC PREPARATION AND USE

 #6
20240148860
2024-05-09

Vaccine for use in the prophylaxis and/or treatment of a disease

 #7
20230181716
2023-06-15

A VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE

 #8
20220387580
2022-12-08

Vaccine for use in the prophylaxis and/or treatment of a disease

 #9
20220347291
2022-11-03

Vaccine for use in the prophylaxis and/or treatment of a disease

 #10
20210353738
2021-11-18

Methods of making and using universal centralized influenza vaccine genes

 #11
20210222197
2021-07-22

VIRUS VECTOR PRODUCTION

 #12
20200155669
2020-05-21

Infectious disease vaccine using non-infectious paramyxovirus particle

 #13
20190209679
2019-07-11

Particulate formulations for enhancing growth in animals

 #14
20190192654
2019-06-27

Microparticulated Vaccines for the Oral or Nasal Vaccination and Boostering of Animals Including Fish

 #15
20190127695
2019-05-02

Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

 #16
20180112178
2018-04-26

Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

 #17
20170350887
2017-12-07

CMV glycoproteins and recombinant vectors

 #18
20170072051
2017-03-16

Particulate formulations for improving feed conversion rate in a subject

 #19
20160090402
2016-03-31

Methods for producing peptides including HERV-W envelope motifs and for producing antibodies specific for the peptides

 #20
20150250864
2015-09-10

ANTI-CANCER VACCINES

 #21
20150152384
2015-06-04

Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

 #22
20140302530
2014-10-09

CMV glycoproteins and recombinant vectors

 #23
20120040010
2012-02-16

Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish

 #24
20110217326
2011-09-08

Method for diagnosing and/or treating tumor

 #25
20100111987
2010-05-06

Methods of diagnosing renal cell carcinoma

 #26
20100086565
2010-04-08

Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV

 #27
20090148454
2009-06-11

Peptide Domain Required For Interaction Between The Envelope of a Virus Pertaining to The Herv-W Interference Group and an Hasct Receptor

 #28
20050232948
2005-10-20

Process for making an adjuvanted vaccine comprising host albumin